Charlotte Radiology is proud to offer our patients the first and only MRI scanner in the Carolinas specifically dedicated to breast imaging and biopsy. Breast MRI is a sophisticated technology that uses a computer, magnetic field and radio waves instead of x-rays to produce images of the soft tissues in the body. This non-invasive procedure helps Charlotte Radiology's board-certified mammography trained physicians to better evaluate the breast in special circumstances. When used in conjunction with screening and diagnostic mammography, it can provide valuable information for the detection and characterization of breast disease.
If MRI is used, it should be in addition to, not instead of, a screening mammogram. While an MRI is more likely to detect cancer than a mammogram, it may still miss some cancers that a mammogram would detect. MRI also has a higher false positive rate (where the test finds things that turn out to not be cancer), which would result in unneeded biopsies and other tests if performed on a large portion of women.
For more information on this and other radiology procedures, please visit www.breast-mri.org.
- have a known BRCA1 or BRCA2 gene mutation
- have a first-degree relative (mother, father, brother, sister, or child) with a BRCA1 or BRCA2 gene mutation, and have not had genetic testing themselves
- have a lifetime risk of breast cancer of about 20% to 25% or greater, according to risk assessment tools that are based mainly on a family history that includes both her mother's and father's side
- had radiation therapy to the chest when they were between the ages of 10 and 30 years
- have a genetic disease such as Li-Fraumeni syndrome, Cowden syndrome, or Bannayan-Riley-Ruvalcaba syndrome, or have one of these syndromes in first-degree relatives
- have a lifetime risk of breast cancer of 15% to 20%, according to risk assessment tools that are based mainly on family history (see below)
- have a personal history of breast cancer, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), atypical ductal hyperplasia (ADH), or atypical lobular hyperplasia (ALH)
- have extremely dense breasts or unevenly dense breasts when viewed by mammograms
Several risk assessment tools, such as BRCAPRO and the Claus model are available to help health professionals estimate a woman's risk. The results should be discussed between a woman and her physicians when they are used to recommend Breast MRI screening. Genetic risk assessment and counseling is also available at Levine Cancer Institute (CHS) by calling 980-442-2000.
- Cardiac Pacemaker
- Artificial heart valve prostheses
- Aneurysm clips
- Eye implants or metal ear implants or any metal implants activated electronically, magnetically or mechanically.
- Copper 7 IUD
- Shrapnel or non-removed bullet
- Weight over 350 lbs
- Any metal puncture(s) or fragment(s) in eye